Beginning in January 2021, the U.S. government prioritized ensuring continuity...Leer más
Variants of SARS-CoV-2, the virus that causes COVID-19, are expected to continue to emerge. Some will emerge and disappear, and others will emerge and continue to spread and may replace previous variants. For example, the variant of the virus that caused the first U.S. COVID-19 cases in January 2020 is no longer detected among variants circulating in the country.
CDC’s national SARS-CoV-2 genomic surveillance program identifies and tracks SARS-CoV-2 variants circulating in the United States and calculates the proportion of variants causing infections, nationally and by HHS region. The thousands of sequences provided every week through CDC’s national genomic surveillance efforts fuel the comprehensive and population-based U.S. surveillance system required to monitor the spread of variants.
Widespread, rapid genomic sequencing provided by the program, combined with phenotypic data, are used to determine whether COVID-19 tests, treatments, and vaccines authorized for use in the United States will work against emerging variants.
Nowcast is a model that projects more recent proportions of circulating variants and enables timely public health action. CDC providing weekly Nowcast estimates which will be updated every week on Tuesday.
Créditos: Comité científico Covid